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1078–5884/00Treatment of Mycotic Aortic Aneurysms with
Endoluminal Grafts
K.G. Jones,1 R.E. Bell,1 T. Sabharwal,2 M. Aukett,1 J.F. Reidy2 and P.R. Taylor1*Departments of 1Vascular Surgery, and 2Radiology, Guy’s and St Thomas’ Hospital, London SE1 7EH, UKPurpose. To report the benefit of endoluminal repair of mycotic aortic aneurysms and highlight the need for a registry.
Methods. Nine patients (five female) were identified over 5 years (1998–2003) as having presumed mycotic aortic
aneurysms (12 in total) suitable for endoluminal grafting. A total of nine thoracic and three abdominal were grafted and
followed up for a median of 36 months.
Results. Six of the aneurysms have resolved and one was converted to an open repair. There was one early death from
rupture of a second undiagnosed aneurysm and two late deaths from rupture due to persistent inflammation. Long-term
antibiotics have not been mandatory to ensure survival.
Conclusions. Mycotic aortic aneurysms of the thoracic and abdominal aorta do benefit from endoluminal repair,
particularly when arising in previously normal aortic tissue. Endoluminal grafting also has a role in the palliation of
secondarily infected aortas and so to prove its efficacy in the treatment of all these rare cases a registry is required.Keywords: Mycotic aneurysm; Endovascular stent graft; Thoracic aorta; Abdominal aorta; Infected false aneurysm.Introduction
Mycotic aneurysmswere first described by Osler in his
Gulstonian lecture of 1851 on malignant endocarditis1
and although they may be life threatening they are
relatively uncommon. The termmycotic aneurysm is a
misnomer as it is applied to bacterial rather than
fungal infection. Its use should perhaps be restricted to
those aneurysms resulting from bacteria originating in
a distant site of infection, which has been estimated to
account for 0.85% of all aortic aneurysms.2 The
traditional treatment of infected aneurysms is excision
of the aneurysm with debridement of the surrounding
infected inflammatory tissue followed by either in situ
repair or extra-anatomical bypass.3 The largest recent
series showed that open surgery was associated with
significant morbidity and mortality.4 The operative
mortality rate was 36% and was probably related to
85% of the cases being ruptured. There are an
increasing number of reports in the literature of
endovascular treatment of both the thoracic and the
infra renal aorta for infected false mycoticing author. P.R. Taylor, Department of Vascular
’s and St Thomas’ Hospital, Lambeth Palace Road,
7EH, UK.
: taylorvasc@aol.com
0139+ 06 $35.00/0 q 2004 Elsevier Ltd. All rights reseraneurysms.5–7 These have confirmed the technical
feasibility of endoluminal repair, however, the num-
bers are small and the follow-up is short so that more
evidence is required before this treatment can be
recommended.8–14 We describe our experience with
nine patients who underwent endovascular stenting
for mycotic aneurysms in the five-year period 1998–
2002 and their subsequent follow-up.Patients and Methods
Since 1998 patients presenting with infected false
aneurysms of the aorta in which open repair was
thought to be too hazardous, were assessed for
suitability for endoluminal repair. Contrast CT scans
and angiography were used to investigate such
patients. Nine patients with a total of 12 mycotic
aneurysms were identified as suitable for endovascu-
lar treatment either alone or as a hybrid procedure
with open surgery. The case details are summarised in
Table 1. During this period another two patients
underwent open surgery for mycotic aortic aneur-
ysms. One patient presented with a history of back
pain and fever following Salmonella gastroenteritis
(Fig. 1). Two patients had undergone previous thoracic
aortic grafts, one for aortic transection and one forEur J Vasc Endovasc Surg 29, 139–144 (2005)
doi:10.1016/j.ejvs.2004.11.008, available online at http://www.sciencedirect.com onved.
Table 1. Patient demographics
Patient Age (yrs) Sex Aneurysm
site (s)
Infective his-
tory
Antibiotics used post op Device used
(material)
114 58 F Thoracic Aorto-oeso-
phageal fis-
tula
Initially two doses augmentin only
when recurrent symptoms started on
ciprofloxacin 500 mg bd
AneuRx
(polyester)
2 64 F Thoracic and
infra renal
History of
fever only
Two doses augmentin 1.2 g Gore and
open (PTFE)
3 62 M Thoracic!2 History only None AneuRx
(polyester)
410 76 M Thoracic MRSA sepsis Linezilid for 6 weeks Gore (PTFE)
5 60 F Thoracic Salmonella None Gore (PTFE)
6 69 F Thoracic Aorto-
cutaneous
fistula
Augmentin for 4 weeks Gore (PTFE)
7 72 F Thoracic Aorto-bron-
chial fistula
Augmentin for 4 weeks Talent
(polyester)
8 80 M Thoracic and
infra renal
No culture?
Salmonella
Metronidazole for C. diff due to pre stent
treatment
Talent and
cook (polye-
ster)
9 40 M Infra renal Pneumococ-
cal septicae-
mia
Two doses augmentin 1.2 g Cook (polye-
ster)
Median 69
years
Five female
four male
Nine thoracic
three infra
renal
K. G. Jones et al.140acute type B dissection. The first developed an aorto-
oesophageal fistula and the second an aorto-bronchial
fistula. Another patient presented with an aorto-
cutaneous fistula following previous radiotherapy
for breast cancer (Fig. 2). Two patients required right
to left carotid–carotid bypass so that the origin of the
left common carotid artery could be covered by the
endograft.
Follow-upwas by CTscan at 3 months and annually
thereafter unless there was a clinical incident requiring
urgent investigation when further CT scans were
performed.Results
The results are summarised in Table 2. One patient
who had synchronous false aneurysms of both the
thoracic and abdominal aorta treated simultaneously
developed paraplegia perioperatively. This was trea-
ted immediately with drainage of the cerebrospinal
fluid which reversed the neurological symptoms
within 24 h. He developed haemoptysis secondary to
a pulmonary embolus, which required treatment with
anticoagulation, and also had diarrhoea secondary to
Clostridium difficile which was treated with metronida-
zole. He was given no long-term antibiotics and
remains well. He was one of five patients who had
complete resolution of their aneurysms without the
need for long-term antibiotics. One patient presented
at 6 weeks with haemoptysis due to a type oneEur J Vasc Endovasc Surg Vol 29, February 2005endoleak. This was treated with coil embolisation,
which failed, and the graft was removed at open
surgery. This patient also presented with synchronous
thoracic and infrarenal false aneurysms, and required
an open repair of the infrarenal aneurysm for an
acutely ischaemic leg following the thoracic endograft.
There were three deaths. One patient died from a
second unsuspected false aneurysm after 2 days before
another device could be procured. One patient with an
aorto-cutaneous fistula died after 5 months from an
infected graft following cessation of antibiotic therapy
(Fig. 3). The patient with an aorto-oesophageal fistula
developed further haematemesis and had a further
endograft but this became infected. She refused open
surgery and died of a massive bleed at 62 months.Discussion
Infected false aneurysms (mycotic) of the aorta are an
uncommon occurrence but present a formidable
challenge with regard to their management. Tra-
ditional teaching supports open surgical treatment
with debridement of infected tissue and in situ repair
with antibiotic soaked grafts.4 In the abdominal aorta,
deep veins have been used as an effective autologous
conduit.16 An alternative is to oversew the aorta and
perform an extra anatomical bypass.4,15 However, in
the largest recent series the mortality for open mycotic
aneurysm repair was 36%. The advances and lower
mortality now associated with endovascular repair
Fig. 1. (a) A false aneurysm of the aorta just above the coeliac axis. (b) An angiogram confirming a false aneurysm. (c) The
aneurysm has been excluded with a stent graft. (d) CT scan after 2 years showing complete resolution of the false aneurysm.
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aneurysms but this approach remains controversial
due to the placement of the stent-graft in an infected
field. The lack of debridement goes against surgical
teaching, however, there have been case reports ofendovascular cases that have remained well up to 2
years following their procedure. Stanley et al. in their
report of four patients describe long-term antibiotics as
being a mandatory component of endovascular treat-
ment of infected aneurysms,13 however, this may notEur J Vasc Endovasc Surg Vol 29, February 2005
Fig. 2. An aortocutaneous fistula in a area of damaged skin
secondary to radiotherapy.
K. G. Jones et al.142be the case as approximately a quarter of tissue
cultures from surgical debridement of mycotic aneur-
ysms show no bacterial growth.
We have reported nine cases where endoluminal
stenting was used to treat aortic false aneurysms,
which were all assumed to be infected despite lack of
positive blood cultures. This is consistent with
previous studies.2,4,15 In five of these cases the
treatment has been entirely successful with a total of
six false aneurysms being excluded and subsequently
resolving with a range of follow-up from 16 to 42
months. In four of these cases the aneurysms had
arisen after a previous infective episode in previouslyTable 2. Late results
Patients Thirty day
mortality
Thirty day morbidity Length
follow
(month
1 Alive – 62
2 Alive Limb ischaemia requiring open
infra renal AAA repair
56
3 Died of
ruptured
unstented
aneurysm
day 2
0
4 Alive – 42
5 Alive – 36
6 Alive 5
7 Alive – 28
8 Alive Recurrent bleed requiring prox-
imal extension cuff. Paraplegia
resolved on CSF drainage, PE,
and C. diffcolitis
27
9 Alive – 16
One death Two early complications Median
36 mon
Eur J Vasc Endovasc Surg Vol 29, February 2005normal aorta. The remaining cases were a higher risk
group of a false aneurysm at the site of a thoracic graft
anastomosis presenting as an aorto bronchial fistula.
These results support the fact that where open surgery
is high risk in the presence of a mycotic aneurysm in
previously non-aneurysmal aorta it is feasible in both
the short and median/long term to perform an
endoluminal repair. We did have an early fatality in
such a patient but this was due to the rupture of a
previously undiagnosed second aneurysm that was
unable to be stented at the initial procedure due to lack
of availability of a suitable device. Mycotic aneurysms
are often multiple and we would recommend that
careful imaging of the whole of the thoracic and
abdominal aorta is performed to exclude any other
synchronous silent pathology. In the other case of
endoluminal stenting of a primarily infected aorta the
procedure was technically unsuccessful with a prox-
imal endoleak despite the hybrid approach of carotid-
to-carotid bypass and endoluminal coils, however, this
patient was successfully converted to an open repair.
The two remaining cases which both led to late
deaths highlight the scenario where in a grossly
abnormal tissue field, the endoluminal stent will not
provide curative treatment but since open surgery is
considered to be a very high risk, there is the possible
role for palliation when combined with antibiotics as
suggested by Stanley et al.13 It may be debatable as to
whether it was appropriate to treat the aorto-
cutaneous fistula but in this patient she had a good
quality of life for her last 5 months. Thus in selectedof
up
s)
Late mor-
tality
Aneurysm
resolution
Late stent morbidity
Died No Recurrent haematemesis at 52
months, successful restenting,
symptoms recurred 10/12 later
Alive No Persistent proximal endoleak,
failed coiling, open repair at 6
weeks
No
Alive Yes –
Alive Yes –
Died No Recurrent bleed from fistula, fatal
Alive Yes –
Alive Yes in both
case
Alive Yes Left leg claudication requiring
Fem–Fem cross over graft
Z
ths
Two
deaths
Four late complications
Fig. 3. (a) An arch angiogram showing the false aneurysm at the origin of the left subclavian artery. A coil has been placed in
the distal left subclavian artery. (b) A right to left carotid–carotid bypass has been performed allowing the stent graft to be
deployed just distal to the brachiocephalic artery. (c) Deployment of the stent graft distal to the brachiocephalic artery
showing exclusion of the false aneurysm.
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patients against imminent rupture and death whilst
accepting that residual infected foreign material will
prevent resolution and that where surgery isconsidered to be too high a risk, life-long antibiotics
would be required.
In conclusion, this small series shows that some
patients with false aortic aneurysms of the thoracicEur J Vasc Endovasc Surg Vol 29, February 2005
K. G. Jones et al.144and abdominal aorta may benefit from endoluminal
repair. This particularly applies to those with aneur-
ysms affecting previously normal aortic tissue. Endo-
luminal repair of false aneurysms in such patients
gives medium term results, which equate or are better
than the most recent series of open repair.4,15 To
answer the questions of long term success and the
usage of long term antibiotics we feel that a multi-
centre trial is required to compare against open repair
and to determine the most appropriate graft material
to use in an infected field.17 However, given the rarity
of the condition, a registry of endoluminal repair of
false aneurysms may be the most pragmatic way of
proving their efficacy.References
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